Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 321 results for "zydus cadila"

Buy Cadila Healthcare; tgt of Rs 1410: Firstcall Research

Firstcall Research report on Cadila Healthcare Zydus Cadila, a global healthcare provider was founded by Late Mr. Ramanbhai B. Patel in 1952. In 1995, the group restructured its operations and emerged with a new identity under the aegis of Zydus ..., 11 hours ago

19 images for zydus cadila

India TV, 1 week ago
Business Today India, 1 week ago
Business Standard India, 1 week ago, 1 month ago
NDTV Profit, 1 month ago, 1 month ago
Money Control, 1 month ago
FDA News, 1 month ago
Bio Spectrum Asia, 2 months ago
NDTV Profit, 1 month ago

SugarFree launches nationwide Donate Your Calorie campaign with

Speaking at the launch, Mr Ganesh Nayak, ED and COO, Zydus Cadila, said, The idea of this cause campaign stemmed from the insight that while a large proportion of India had excess calorie consumption leading to a state of unhealthiness or weight ...
 Web Newswire2 weeks ago Zydus wellness ties up with NGO Donate Your Calories to help nourish children campaign  India Retailing2 weeks ago Zydus Wellness : Akshay Kumar unveiled the 'Donate Your Calories To Help Nourish Children' campaign in Mumbai  4 Traders2 weeks ago 'Donate Your Calories' says Sugar Free  Agencyfaqs!2 weeks ago
India TV

Zydus gets USFDA nod to market anti-diabetic tablets; closes down 1.15%

Cadila Healthcare closed today at 1.15% at Rs. 1,272 on BSE. The stock opened at Rs. 1,300 and closed at Rs. 1,272. The stock hit a high of Rs. 1323 and a low of Rs. 1,262. Zydus Cadila has received tentative approval from the USFDA to market ...
 India Infoline2 weeks ago Cadila Health up 3%, diabetic drug gets tentative USFDA nod  Money Control2 weeks ago Zydus Cadila gets tentative approval from US FDA for Glipizide ER tablets  Indian-Commodity2 weeks ago Zydus gets USFDA tentative nod for diabetic tablets  Press Trust of India2 weeks ago
FDA News

Zydus gets Gilead licence for Hepatitis C treatment

Cadila Healthcare Ltd (Zydus Cadila) on Monday said it has been granted generic licence by Gilead Sciences Inc, to manufacture breakthrough treatment of Hepatitis C. The two companies have entered into a generic, non-exclusive licensing agreement ...
 Hindu Business Line2 weeks ago Zydus and Gilead Enter into a Generic Licensing Agreement to manufacture breakthrough treatment for Hepatitis C  Equity Bulls2 weeks ago Zydus inks pact with Gilead Sciences to produce and distribute Hepatitis C drug  Indian-Commodity2 weeks ago Zydus granted license to produce generic hepatitis C drug  Smart Investor2 weeks ago

Zydus Cadila sales target

Homegrown drug major Zydus Cadila has set a target of clocking a consolidated turnover of over Rs 10,000 crore by FY'16. "We will have a revenue of Rs 10,000 crore in FY16. We closed last fiscal with a revenue of Rs 7,208 crore," Zydus Cadila Chief ...
 The Echo Of India2 weeks ago Zydus Wellness : CADILA SETS SALES TARGET OF Rs10,000 CRORE  4 Traders2 weeks ago Zydus Cadila sets Rs 10,000 cr sales target by FY16  Business Standard2 weeks ago Zydus Cadila Targets Rs 10,000 Crore Sales by FY16  NDTV2 weeks ago
Business Standard

Zydus Cadila bags license for hepatitis C drug

medabad-based pharma major Cadila Healthcare (Zydus Cadila) today announced that it has signed a non-exclusive licensing agreement with Gilead Sciences Inc, which will allow the generic manufacture of sofosbuvir and ledipasvir (used for treatment of chronic ...
 Business Standard2 weeks ago
Business Standard India

Novartis files lawsuit against Zydus for patent infringement in US

Ahmedabad-based Cadila Healthcare Ltd (Zydus Cadila) is facing lawsuits in US court, including that filed by global pharma major Novartis Pharmaceuticals, for infringement of patents. Novartis has filed two suits against Cadila Healthcare's US ...
 Business Standard India3 weeks ago

Drug price reduction to impact Sanofi, Zydus Cadila, Ranbaxy most: Experts

Drug price reduction to impact Sanofi, Zydus Cadila, Ranbaxy most: Experts Source: IRIS (14-JUL-14) In a rare invocation of a lesser-used provision in the Drug Price Control Order (DPCO), NPPA has fixed the prices of 108 formulation packs of 50 anti-diabetic ...
 Myiris2 months ago

Pankaj Patel passes on baton to son at Zydus Wellness

Pankaj Patel will continue to remain the chairman and managing director of Cadila Healthcare of which Zydus Wellness is a subsidiary
 Business Standard2 months ago Pankaj Patel passes on reigns to son at Zydus Wellness  Business Standard2 months ago

"Zydus Cadila Healthcare Limited - Product Pipeline Review - 2014" Published

Boston, MA -- (SBWIRE) -- 08/28/2014 -- Zydus Cadila Healthcare Limited - Product Pipeline Review
 SearchBug1 month ago Zydus Cadila Healthcare Limited - Product Pipeline Review - 2014  MarketResearch.com1 month ago Biocon : Market Report, "Biocon Limited - Product Pipeline Review - 2014", published  4 Traders1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - zydus cadila
Get updated on latest news & your favorite topics right in your inbox!
More     Less